申请人:Shah Lipa
公开号:US20130338061A1
公开(公告)日:2013-12-19
The invention provides new salts and polymorphs of (5R,8S)-7-[(2S)-2-[(2S)-2-cyclohexyl-2-([(2S)-1-isopropylpiperidin-2-yl]carbonyl}amino)acetyl]amino}-3,3-dimethyl butanoyl]-N-(1R,2R)-2-ethyl-1-[(pyrrolidin-1-ylsulfonyl)carbamoyl]cyclopropyl}-10,10-dimethyl-7-azadispiro[3.0.4.1]decane-8-carboxamide (referred to herein as Compound X), pharmaceutical compositions containing them and processes for their manufacture and use in therapy.
本发明提供了(5R,8S)-7-[(2S)-2-[(2S)-2-环己基-2-[(2S)-1-异丙基哌啶-2-基]羧酰基}氨基]乙酰}氨基]-3,3-二甲基丁酰]-N-(1R,2R)-2-乙基-1-[(吡咯烷-1-磺酰)氨基甲酰]环丙基}-10,10-二甲基-7-氮杂二环[3.0.4.1]癸烷-8-羧酰胺(以下简称化合物X)的新盐和多晶形态,包含它们的制药组合物以及在治疗中使用的制备和使用方法。